1. Home
  2. ASIC vs CRVS Comparison

ASIC vs CRVS Comparison

Compare ASIC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASIC

Ategrity Specialty Insurance Company Holdings

HOLD

Current Price

$23.83

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$13.24

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASIC
CRVS
Founded
2018
2014
Country
United States
United States
Employees
203
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
ASIC
CRVS
Price
$23.83
$13.24
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$26.75
$30.17
AVG Volume (30 Days)
65.1K
1.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$34.21
N/A
Revenue Next Year
$34.65
N/A
P/E Ratio
$98.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.35
$4.05
52 Week High
$26.00
$26.95

Technical Indicators

Market Signals
Indicator
ASIC
CRVS
Relative Strength Index (RSI) 49.56 42.99
Support Level $22.12 $12.95
Resistance Level $23.49 $14.00
Average True Range (ATR) 1.21 0.71
MACD -0.09 -0.23
Stochastic Oscillator 34.63 22.47

Price Performance

Historical Comparison
ASIC
CRVS

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: